Sanofi Genzyme Support Services

Managing a genetic disease is a lifetime commitment. From diagnosis to treatment, our dedicated team of professionals is available to provide disease education and help address your needs, including assistance with health insurance issues, all free of charge.

  • For newly diagnosed patients: We provide in-person education and disease-specific resources
  • For patients just starting treatment: Our insurance verification assistance also provides treatment location options and logistical troubleshooting as well as treatment-specific resources and answers to treatment-related questions
  • For patients who are traveling or moving: We can help locate treatment centers, doctors, and other resources at their destination
  • For patients who may be changing jobs: We provide insurance transition assistance
  • For those in need of assistance with family matters: We provide information on medical family trees, genetics testing, and diagnostic labs for patients who may be planning on starting a family or want more information for their siblings or relatives

Access to these and other services is voluntary, and you are not obligated to begin treatment if you contact us. You and your doctor make all treatment-related decisions, and most importantly the privacy and security of your personal situation is always protected.

For more information, contact Sanofi Genzyme Support Services at 800-745-4447 (option 3), Monday-Friday, 8:00 AM to 6:00 PM EST


The Sanofi Genzyme Support Services Team

It is our commitment to always deliver the same unparalleled, personalized patient support through our experienced and connected team of case managers and patient education liaisons.

Sanofi Genzyme Case Managers (CM)

  • Serve as the primary point of contact at Sanofi Genzyme for patients
  • Provides care coordination to support your needs
  • Have expertise in health insurance and in navigating the health care system

Sanofi Genzyme Patient Education Liaisons (PEL)

  • Have a background in nursing or genetic counseling
  • Provide in-person disease education to you, your family, and others (eg, schools and employers)
  • Here to help you understand how the disease is passed on in families and can complete a medical family tree
  • Are regionally based 

Spanish-speaking Case Managers are available, as well as interpreters for other languages.

Information you provide will always be kept confidential.

Indication & Usage

Cerezyme® (imiglucerase for injection) is indicated for long-term enzyme replacement therapy for pediatric and adult patients with a confirmed diagnosis of Type 1 Gaucher disease that results in one or more of the following conditions:

  1. anemia (low red blood cell count)
  2. thrombocytopenia (low blood platelet count)
  3. bone disease
  4. hepatomegaly or splenomegaly (enlarged liver or spleen)

Important Safety Information

Approximately 15% of patients have developed immune responses (antibodies) to Cerezyme during the first year of therapy. These patients have a higher risk of an allergic reaction (hypersensitivity). Your doctor may periodically test for the presence of antibodies. Serious allergic reactions (anaphylaxis) have been reported in less than 1% of patients. Symptoms suggestive of allergic reaction happened in approximately 7% of patients, and include itching, flushing, hives, swelling, chest discomfort, shortness of breath, coughing, cyanosis (a bluish discoloration of the skin due to diminished oxygen), and low blood pressure. If you have had an allergic reaction to Cerezyme, you and your doctor should use caution if you continue to receive treatment with Cerezyme.

High blood pressure in the arteries of the lungs (pulmonary hypertension) and pneumonia have been observed in less than 1% of patients during treatment with Cerezyme. These are also known complications of Gaucher disease regardless of treatment. If you experience symptoms such as shortness of breath or chest pain, with or without fever, contact your doctor.

Approximately 14% of patients have experienced side effects related to treatment with Cerezyme. Some of these reactions occur at the site of injection such as discomfort, itching, burning, swelling or uninfected abscess. Other side effects, each of which was reported by less than 2% of patients, include nausea, abdominal pain, vomiting, diarrhea, rash, fatigue, headache, fever, dizziness, chills, backache, and rapid heart rate. Temporary swelling in the legs has also been observed with drugs like Cerezyme.

Please see Full Prescribing Information (PDF).

You may report side effects to the FDA at 1-800-FDA-1088.

Reference 1. Data on file. Genzyme Corporation; Cambridge, MA.